 But then now we're talking about a different category, and that's fibrolemellar carcinoma, which does generally, forgive me if it's all the time, originate in the liver, but it's of a different tissue type in the liver. Is that correct? Probably. We don't know which tissue type it is, but you bring up a good point. What we know for sure is it absolutely is not hepatocellular carcinoma, but that's one of the major reasons we started this foundation is the misconception that it is somehow related to HCC. It's the eighth most common cancer in the world, and this is a cancer that occurs in 100 patients a year in the entire United States. It's ungodly rare. Most physicians have never seen it, including cancer physicians have never seen it in their entire career. So yes, we don't know the cell of origin. It's probably biliary and probably closely related to cholangiocarcinoma, but it always starts in the liver. That's correct. And you know, at least with HCC, there's usually some degree of underlying pathology. So if you have hemochromatosis and you have a ton of iron deposition, which causes cirrhosis, or alcoholic cirrhosis, or hepatitis cirrhosis, related cirrhosis, but here, I presume that fibrillamela does not require liver pathology underlying beforehand, or is it something that needs to be like, is there really correct? You're correct. There's never underlying pathology, and that's another common misconception. And one of the problems with research is because the research will often lump this together with HCC. Three problems. Number one, it's not HCC. Number two, those are 85% of the time people with unhealthy livers with cirrhosis and alcoholism and hepatitis and everything else. And number three, they're almost always elderly and deconditioned. So everything you're doing with them is very fragile. You're very careful. You're so worried about the liver function and all of that. And that's none of that applies to fibrillamela. And consequently, the patients are mistreated and under-treated.